急性胰腺炎早期高能量与逐步增加能量营养策略比较:GOULASH多中心双盲随机临床试验
该多中心双盲随机试验纳入636例急性胰腺炎患者,比较早期高能量(30 kcal/kg/d)与逐步增加能量(4天内从0增至30 kcal/kg/d)肠内营养策略。因无效性提前终止,主要终点(死亡和重症急性胰腺炎)两组无差异(HE 9.0% vs LE 5.7%,p校正=0.42)。未校正多重检验时低能量策略在器官衰竭和疼痛复发方面更优,但校正后无差异;高能量策略不降低死亡率/ severity,但可能增加器官衰竭和疼痛复发。
要点
- 急性胰腺炎早期高能量肠内营养不降低死亡和重症胰腺炎发生率。
- 高能量策略可能增加器官衰竭和疼痛复发风险,但校正多重检验后无统计学差异。
- 因无效性提前终止,支持早期逐步增加能量而非直接高能量营养。
核心结论
- 急性胰腺炎早期高能量营养策略不降低死亡率/重症率,但可能增加器官衰竭和疼痛复发率。
研究设计与样本
- 多中心、双盲、随机临床试验,纳入急性胰腺炎患者(不限预测严重程度),2017年1月至2023年4月,计划中期分析后提前终止,共636例。
主要发现
- 主要终点(死亡和重症急性胰腺炎复合)在mITT人群无差异:HE组28/312(9.0%)vs LE组18/307(5.7%),p未校正/校正=0.19/0.42。
- 未校正多重检验时,低能量策略在器官衰竭(HE 52/312(16.7%)vs LE 28/307(9.1%),p未校正=0.007)和疼痛复发(HE 80/312(27.1%)vs LE 54/307(19.0%),p未校正=0.03)方面更优。
- 校正多重检验后,器官衰竭和疼痛复发差异无统计学意义(p=0.13和p=0.23)。
关键数值与推荐
- 高能量策略:30 kcal/kg/天;低能量策略:4天内从0逐步增加至30 kcal/kg/天。
- 主要终点为死亡和重症急性胰腺炎(修订版亚特兰大标准)的复合终点。
- 采用Benjamini-Hochberg假发现率(FDR)法校正多重检验p值。
临床怎么用
- 急性胰腺炎早期肠内营养不宜直接采用高能量策略,可考虑逐步增加能量。
- 高能量策略可能增加器官衰竭和疼痛复发,需谨慎评估。
局限性
- 试验因无效性提前终止,样本量有限。
- 次要终点结果在校正多重检验后无统计学差异,需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute pancreatitis (AP) is among the most common gastrointestinal diseases requiring hospitalisation, often with severe outcomes and no disease-specific therapy. Nutritional support has been proven to improve outcome, but little is known regarding optimal timing and composition. OBJECTIVE: This clinical trial aimed to compare high (30 kcal/kg/day, high energy (HE)) versus gradually increasing energy (0 increased to 30 kcal/kg/day over 4 days, low energy (LE)) strategies for enteral nutritional support in AP. DESIGN: This was a multicentric, double-blind, randomised clinical trial, enrolling patients with AP regardless of predicted severity (January 2017 to April 2023). The primary outcome was a combination of mortality and severe acute pancreatitis (Revised Atlanta Criteria); secondary outcomes included severity, rate of infection, organ failure and pain relapse. Interim analysis was planned after 50% enrolment. The Benjamini-Hochberg false discovery rate (FDR) method was used to correct p value for multiple testing. RESULTS: The trial was stopped early after enrolling 636 patients. Interim analysis showed that the primary outcome showed no difference between groups in the modified intention-to-treat (mITT) population (HE: 28/312, 9.0% vs LE: 18/307, 5.7%, p(uncorrected/corrected)=0.19/0.42). Secondary outcomes showed no difference in the mITT analysis. Without correction for multiplicity testing, results favoured a low gradual energy strategy in terms of organ failure (HE: 52/312, 16.7% vs LE: 28/307, 9.1%, p(uncorrected)=0.007) and pain relapse (80/312, 27.1% vs 54/307, 19.0% p(uncorrected)=0.03) but showed no differences between groups after correction for multiple testing (p=0.13 and p=0.23, respectively). It was determined that the superiority of the intervention would not be shown even with an increased sample size, and thus the trial was terminated based on a post hoc decision on ethics and futility. CONCLUSION: Based on this early terminated trial, a high-energy strategy for early nutrition in pancreatitis does not decrease mortality/severity, but potentially increases organ failure and pain relapse rate. TRIAL REGISTRATION NUMBER: ISRCTN63827758.
引用
- Márta K, Engh MA, Vincze Á, et al. High versus gradually increasing energy nutrition in the early phase of acute pancreatitis (GOULASH): a multicentre double-blind randomised clinical trial. Gut. 2026. PMID: 41786585. doi:10.1136/gutjnl-2025-335970
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。